IPC2BNSConverter

BNS Section 278 · Deep dive

BNS Section 278 (IPC 276): Sale of Drug as a Different Drug or Preparation (Ingredients & Law)

Section 278 of the Bharatiya Nyaya Sanhita, 2023 (replacing Section 276 IPC) punishes anyone who knowingly sells, offers or exposes for sale, or issues from a dispensary for medicinal purposes, any drug or medical preparation as a different drug or medical preparation S1, s. 278; S4, s. 276. Unlike Sections 276 and 277 BNS, Section 278 BNS does not require the drug to be adulterated, impure, or noxious; knowingly dispensing or selling even a pure medicine under the identity of a different medicine completes the offence S1, ss. 276–278. The BNS retains the maximum sentence of six months' imprisonment of either description while increasing the maximum fine from ₹1,000 to ₹5,000 S1, s. 278; S4, s. 276.

By the Nyaya Yantra Editorial TeamLaw checked as of 16 October 2026 9 min read

Prepared with AI-assisted research from the official sources listed at the end of this article.

At a glance

Provision
BNS Section 278 — Sale of drug as a different drug or preparation
Earlier law (IPC)
Section 276 · direct
Side-by-side converterIPC 276 → BNS 278

1. Statutory Text and Distinct Place in Substantive Criminal Law

Section 278 of the Bharatiya Nyaya Sanhita, 2023 (BNS) completes the pharmaceutical triad in Chapter XV by criminalising the knowing substitution or mislabelling of one drug or medical preparation for another S1, s. 278. The enacted Gazette text reads verbatim:

278. Sale of drug as a different drug or preparation.—Whoever knowingly sells, or offers or exposes for sale, or issues from a dispensary for medicinal purposes, any drug or medical preparation, as a different drug or medical preparation, shall be punished with imprisonment of either description for a term which may extend to six months, or with fine which may extend to five thousand rupees, or with both. S1, s. 278

The Crucial Legal Distinction Between Sections 276–277 and Section 278 BNS

Practitioners and students frequently conflate Section 277 BNS (Sale of adulterated drugs) with Section 278 BNS (Sale of drug as a different drug or preparation). The substantive distinction is fundamental S1, ss. 276–278:

  • Under Sections 276 and 277 BNS, the drug itself must have been adulterated (mixed, diluted, or chemically altered so as to lessen its efficacy, change its operation, or render it noxious) S1, ss. 276, 277.
  • Under Section 278 BNS, the drug or medical preparation sold or dispensed need not be adulterated, impure, or noxious at all S1, s. 278. Even if Drug $X$ (say, pure paracetamol) is 100% genuine and chemically unblemished, knowingly selling, exposing for sale, or issuing Drug $X$ from a dispensary as Drug $Y$ (say, as an anti-epileptic or cardiac drug) commits the offence under Section 278 BNS S1, s. 278; S7, paras 6–10. The mischief targeted by Section 278 is therapeutic substitution and misrepresentation of medicinal identity, which deprives the patient of the intended medicine and exposes them to the unconsented pharmacological action of a different substance.

2. Exact Offence Ingredients and Mental Element (Mens Rea)

To establish an offence under Section 278 BNS, the prosecution must prove three cumulative ingredients S1, s. 278:

  1. Subject Matter (Any Drug or Medical Preparation):
    • The article involved must be a drug or medical preparation, whether allopathic, ayurvedic, unani, siddha, homoeopathic, or compounded clinical formulation S1, s. 278; S7, paras 6–10.
  2. Prohibited Conduct and False Identity Representation (Actus Reus):
    • The accused must:
      • (a) sell,
      • (b) offer or expose for sale, or
      • (c) issue from a dispensary for medicinal purposes that drug or medical preparation as a different drug or medical preparation S1, s. 278.
    • Note that, unlike Section 277 BNS (which has a fourth limb covering "causes it to be used for medicinal purposes by any person"), Section 278 BNS is confined to the three commercial/dispensary channels: selling, offering/exposing for sale, and issuing from a dispensary for medicinal purposes S1, ss. 277, 278.
    • Furthermore, the offence does not require proof of pecuniary loss to the buyer (unlike cheating under Section 318 BNS) or actual physical hurt to the patient; even if the substituted preparation happens to be more expensive or harmless, the offence is complete upon the knowing sale, offer/exposure, or dispensary issue as a different drug S1, ss. 278, 318.
  3. Mental Element ("Knowingly"):
    • The adverb "knowingly" governs the entire predicate S1, s. 278. The accused must know both (i) the true nature/identity of the drug or preparation being supplied (or at least that it is not the drug represented) and (ii) that it is being sold, offered/exposed for sale, or issued as a different drug or medical preparation S1, s. 278.
    • Honest Dispensing Mistake vs. Knowing Substitution: If a pharmacist, through an honest visual mistake in reading a physician's handwritten prescription or by accidentally picking a look-alike bottle in good faith, dispenses the wrong medicine without knowing it is a different drug, Section 278 BNS is not attracted because the act was not done knowingly S1, ss. 3(1), 17, 278. (Note, however, that if the substance is poisonous and the pharmacist's conduct is rash or negligent so as to endanger human life, liability may separately arise under Section 286 BNS, or if hurt/death ensues, under Sections 125 or 106 BNS S1, ss. 106, 125, 286.)

3. IPC-to-BNS Correspondence and Statutory Comparison

Section 278 BNS directly replaces Section 276 of the Indian Penal Code, 1860 (IPC) S4, s. 276; S5:

AttributeIPC Section 276 (Repealed w.e.f. 01-07-2024)BNS Section 278 (Effective 01-07-2024)Legal & Practical Significance
Section Number & HeadingSection 276: Sale of drug as a different drug or preparation. S4, s. 276Section 278: Sale of drug as a different drug or preparation. S1, s. 278Renumbered by +2 in Chapter XV of the BNS (Note: do not confuse old IPC 276 with new BNS 276, which is old IPC 274!) S5.
Operative IngredientsKnowingly sells, offers/exposes for sale, or issues from a dispensary for medicinal purposes any drug or medical preparation as a different drug or preparation S4, s. 276Identical verbatim wording S1, s. 278Zero change in substantive ingredients or mental standard ("knowingly") S1, s. 278; S4, s. 276.
Maximum ImprisonmentImprisonment of either description up to six months S4, s. 276Imprisonment of either description up to six months S1, s. 278Unchanged S1, s. 278; S4, s. 276.
Maximum FineUp to ₹1,000 ("one thousand rupees") S4, s. 276Up to ₹5,000 ("five thousand rupees") S1, s. 278Five-fold increase in statutory fine ceiling S1, s. 278; S4, s. 276.
Default-of-Fine ImprisonmentUp to 1.5 months (under Section 65 IPC) S4, s. 65Up to 1.5 months (one-fourth of 6 months under Section 8(3) BNS) S1, s. 8(3)Unchanged S1, s. 8(3).

Practitioner Citation Alert: Because Section 276 IPC was renumbered to Section 278 BNS, while Section 274 IPC became Section 276 BNS, FIRs, complaints, and charge-sheets must carefully verify whether the allegation is adulteration (now Section 276 BNS) or sale as a different drug (now Section 278 BNS) S1, ss. 276, 278; S5.

4. Punishment Matrix and Sentencing Mechanics

  • Imprisonment: Up to six months of either description (rigorous or simple, or partly rigorous and partly simple under Section 7 BNS) S1, ss. 7, 278.
  • Fine: Discretionary ("or with fine... or with both"), up to ₹5,000 S1, s. 278.
  • Imprisonment in Default of Payment of Fine: Under Section 8(3) BNS, capped at one-fourth of the maximum imprisonment (i.e., 1.5 months), of either description per Section 8(4) BNS S1, s. 8(3)–(4).

5. Procedural Classification (BNSS 2023) and Special-Law Overlap

Under the First Schedule to the BNSS, 2023, Section 278 BNS is classified as S2, First Schedule:

  • Non-cognizable: Requires a Magistrate's order under Section 174(2) BNSS for police investigation S2, s. 174, First Schedule.
  • Bailable: Bailable as of right S2, First Schedule.
  • Triable by Any Magistrate S2, First Schedule. (Note: While Section 283(1)(i) BNSS specifically names Sections 276 and 277 BNS, Section 278 BNS is also eligible for summary trial by a Chief Judicial Magistrate or Magistrate of the first class under the general clause Section 283(1)(a) BNSS, which covers offences not punishable with death, life imprisonment, or imprisonment for a term exceeding three years S2, s. 283(1)(a), (i).)
  • Non-compoundable under Section 359 BNSS S2, s. 359.

Overlap with Cheating (Section 318 BNS) and Drugs and Cosmetics Act, 1940:

  • Where a seller knowingly passes off a cheap generic preparation as a costly branded biologic to deceive a buyer into paying a higher price, the conduct may simultaneously satisfy Section 278 BNS and Section 318 BNS (Cheating), subject to the single-punishment limit in Section 9 BNS S1, ss. 9, 278, 318.
  • Under the Drugs and Cosmetics Act, 1940, a drug sold under a name which belongs to another drug, or which is an imitation of or a substitute for another drug, is defined as a "spurious drug" under Section 17B (and/or "misbranded" under Section 17), attracting stringent penalties under Section 27 of that Act S6. Pursuant to Union of India v. Ashok Kumar Sharma, (2021) 12 SCC 674, prosecutions under Chapter IV of the 1940 Act are governed by the special complaint mechanism in Section 32 of that Act S6, paras 150–170.

6. Temporal Applicability

Section 278 BNS commenced on 1 July 2024 S3. Offences committed prior to 1 July 2024 must be tried under Section 276 IPC (with the ₹1,000 fine cap) in accordance with Section 358(2) BNS and Article 20(1) of the Constitution, whereas conduct on or after 1 July 2024 is governed by Section 278 BNS (with the ₹5,000 fine cap) S1, ss. 278, 358(2); S4, s. 276.

7. Practical Illustrations and Counterexamples

  • Editorial Hypothetical 1 (Intentional Substitution of Out-of-Stock Medicine: Offence Committed): P, a dispensary pharmacist, runs out of a prescribed anti-hypertensive drug (Amlodipine). Rather than turning the patient away, P knowingly strips the outer packaging from a mild vitamin tablet of identical size and colour, places it in a dispensary envelope labelled Amlodipine, and issues it to the patient. Even though the vitamin tablet is pure and non-toxic, P knowingly issued a drug as a different drug for medicinal purposes and is guilty under Section 278 BNS S1, s. 278.
  • Editorial Hypothetical 2 (Substitution of Herbal/Unani Preparation: Offence Committed): Q, a vendor of traditional medical preparations, knowingly fills bottles labelled "Pure Ashwagandha Extract for Medicinal Use" with a cheaper, entirely different herbal extract (Shatavari) and exposes them for sale in his shop. Q is liable under Section 278 BNS S1, s. 278.
  • Editorial Counterexample 1 (Informed Generic Substitution with Patient Consent: No Offence): R, a chemist, informs a customer that Brand A of Azithromycin 500mg is out of stock and offers Brand B of Azithromycin 500mg, clearly billing and handing it over as Brand B. Because R did not sell or represent Brand B as Brand A or as a different drug, no offence under Section 278 BNS is committed S1, s. 278.
  • Editorial Counterexample 2 (Inadvertent Picking Error: No Offence Under Section 278 BNS): During a rush hour, Chemist S accidentally picks up a box of Losartan instead of Levocetirizine due to adjacent shelving and hands it to a customer believing it to be Levocetirizine. Because S did not act knowingly, Section 278 BNS is not attracted S1, s. 278.

Frequently asked questions

+How does Section 278 BNS differ from Section 277 BNS?
Section 277 BNS applies when a drug has actually been adulterated (lessening its efficacy, changing its operation, or making it noxious) and is sold or issued as unadulterated S1, s. 277. Section 278 BNS applies when a drug, even if completely pure and unadulterated, is knowingly sold, offered/exposed for sale, or issued from a dispensary as a different drug or medical preparation S1, s. 278.
+If a pharmacist accidentally hands over the wrong medicine by misreading a doctor's handwriting, is it an offence under Section 278 BNS?
No. Section 278 BNS expressly requires that the accused act 'knowingly' S1, s. 278. An honest, inadvertent dispensing mistake lacks the mental element required by Section 278 BNS, though rash or negligent handling of a poisonous substance or causing hurt/death by negligence may separately attract Sections 286, 125, or 106 BNS depending on the facts S1, ss. 106, 125, 278, 286.
+Why must practitioners be careful with section numbers when citing IPC 276 versus BNS 276?
Because of the +2 renumbering shift in Chapter XV, old Section 276 IPC ('Sale of drug as a different drug or preparation') is now Section 278 BNS, whereas new Section 276 BNS is old Section 274 IPC ('Adulteration of drugs') S1, ss. 276, 278; S4, ss. 274, 276; S5.

Sources

  1. S1The Bharatiya Nyaya Sanhita, 2023 (Act No. 45 of 2023) — Official Gazette of India Extraordinary, Part II, Section 1, No. 53 (CG-DL-E-25122023-250883) — Ministry of Law and Justice (Legislative Department), Government of India (accessed 16 October 2026)
  2. S2The Bharatiya Nagarik Suraksha Sanhita, 2023 (Act No. 46 of 2023) — Official Gazette of India Extraordinary, Part II, Section 1, No. 54 (CG-DL-E-25122023-250884) — Ministry of Law and Justice (Legislative Department), Government of India (accessed 16 October 2026)
  3. S3Ministry of Home Affairs Notification S.O. 850(E) — Commencement of the Bharatiya Nyaya Sanhita, 2023 — Ministry of Home Affairs, Government of India (accessed 16 October 2026)
  4. S4The Indian Penal Code, 1860 (Act No. 45 of 1860) — Chapter XIV: Of Offences Affecting the Public Health, Safety, Convenience, Decency and Morals — Government of India (archived via Indian Kanoon) (accessed 16 October 2026)
  5. S5Corresponding Section Table of Bharatiya Nyaya Sanhita, 2023 (BNS) and Indian Penal Code, 1860 (IPC) — Uttar Pradesh Police / Bureau of Police Research and Development (accessed 16 October 2026)
  6. S6Union of India v. Ashok Kumar Sharma & Ors., (2021) 12 SCC 674 (Supreme Court of India, decided 28 August 2020) — Supreme Court of India (archived via Indian Kanoon) (accessed 16 October 2026)
  7. S7Chimanlal Jagjivandas Sheth v. State of Maharashtra, AIR 1963 SC 665 (Supreme Court of India, decided 26 September 1962) — Supreme Court of India (archived via Indian Kanoon) (accessed 16 October 2026)

Related deep dives

← All BNS section deep dives